RAMM Pharma Third Quarter 2024 Earnings: CA$0.008 loss per share (vs CA$0.009 loss in 3Q 2023)

Simply Wall St · 09/29 14:15

RAMM Pharma (CSE:RAMM) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CA$1.21m (down 9.2% from 3Q 2023).
  • Net loss: CA$993.8k (loss narrowed by 4.3% from 3Q 2023).
  • CA$0.008 loss per share (improved from CA$0.009 loss in 3Q 2023).
earnings-and-revenue-history
CNSX:RAMM Earnings and Revenue History September 29th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

RAMM Pharma's share price is broadly unchanged from a week ago.

Risk Analysis

We should say that we've discovered 5 warning signs for RAMM Pharma (4 are a bit concerning!) that you should be aware of before investing here.